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SB 726 would amend chapters 321 and 343, HRS, to provide that proposed releases of genetically
modified organisms within the state would be subject to assessment under the state Environmental Impact
Statement (EIS) system.
Our statement on this bill does not constitute an institutional position of the University of Hawaii.
Inclusion of bioengineered organism releases as a trigger for environmental assessment was a
recommendation of the Hawaii State Environmental Impact Statement System report prepared in 1991 by the
Environmental Center. The major concern behind this recommendation is the unique and fragile nature of
Hawaii's environment and the integrity of remaining endemic species and habitats.
Additional concern has arisen as a consequence of proposed federal regulations which would permit
release of genetically modified varieties of certain species in Hawaii and elsewhere without specific review.
Although provision exists within the regulations for notificationof appropriate state officials, such notification
is required only "to be postmarked, or delivered to a commercial express carrier on the day of or prior to the
day of introduction." In other words, an organism may be released in Hawaii, and state officials would not
learn of the release until delivery of mail several days later.
We are sympatheticwith the desire to promote Hawaii as a major location for biotechnicalinnovation,
and we recognize the care which most researchers devote to ensuring that their activities are environmentally
benign. However, the history of quality assurance within the bioengineering and federal regulatory
communities has been less than encouraging.
In 1990, the Monsanto Corporation applied for a federal permit to test a genetically modified strain
of cotton on Kauai. The federal Animal and Plant Health Inspection Service of the US Department of
Agriculture (APHIS) issued a Finding of No Significant Impact based on their assessment of the proposed
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release. However, the field studies submitted by Monsanto to APHIS in support of their application were
conducted in Oklahoma and Pakistan.
Prior to the Monsanto application, Calgene had applied for a permit to introduce genetically modified
cotton on Molokai. At the time, informal notification and review arrangements allowed the State's Review
Committee on Genetically Engineered organisms to respond to this request. The reponse specifically noted
concerns over site-specific environmental factors, including the presence or absence of Hawaii's native cotton
variety, and lack of information on natural pollination vectors for Hawaiian cotton. In response, Calgene
contracted with local experts to perform site-specificsurveys to evaluate regional environmental characteristics.
A number of aspects of this history are troublesome. First, both the National Environmental Policy
Act (NEPA) and Chapter 343, HRS, explicitly address the need for evaluation of a proposed action within
and adjacent to the environment where it will be undertaken. The species assemblage and habitat
characteristics of Molokai and Kauai are critically distinct from those in Pakistan, Oklahoma, Texas, Arizona,
and other locations where cotton studies offered in justification of the proposed action were conducted.
Second, it was apparent from correspondence between local officials and federal and corporate individuals that
the corporation and the federal regulators were unaware of the existence of Hawaiian strains of cotton, and
could not answer fundamental questions about the specific route whereby horizontal gene transfer to the local
strains might be accomplished, thereby potentially altering future generationsof Hawaiian cotton irretrievably.
Finally, we find it particularly unsettling that the deficiencies evident in the prior Calgene application were
not addressed by APHIS in the subsequent Monsanto application.
After careful review of the proposed amendments to federal regulations pertaining to release of
bioengineeredproducts, we remain concerned that the focus of these regulations remains firmly lodged on the
bioengineeringprocess and the resultant organism, not on the potential effect of the organism on the receiving
environment. It should be noted in addition that cotton is one of the species proposed for blanket exemption
from case by case review by the pending APHIS regulations. Had those regulations been in place, the
important questions relating to the cotton tests raised by state officialswould not have been aired prior to the
Hawaii introductions.
While we continue to support the addition of a trigger under Chapter 343 for such introductions, it
may be unfeasible at this time to realize such a review process, given constraints in staff and funds. However,
at a minimum, we stongly urge the Committee to preserve appropriate language in this measure to ensure
continued official state review of proposed introductions of genetically altered organisms.
As with most such issues, the scientific community will not be unanimous in its opinion one way or
another. Members of the biotechnical disciplines have justifiable interests in encouraging relaxation of
regulation perceived to be burdensome. However, we call the Committee's attention to findings of the
Ecological Society of America and published in the journal, Ecology, after extensive peer review by many of
the nation's most preeminent scientists, both ecologists and specialists in biotechnology:
"The report supports the use of advanced biotechnology for the development of
environmentally sound products, and states that the phenotype of a transgenic organism, not
the process used to produce it, is the appropriate focus of regulatory oversight. Ecological
risk assessment of proposed introductions must consider the characteristicsof the engineered
trait, the parent organism, and the environment that will receive the introduced organism."
